March 25th, 2026
This conference has already taken place.
Description
The HALT+/-D procedure is a novel approach for highly allosensitized patients undergoing heart transplants. This procedure involves a reverse dual heart-liver transplant, where the liver is transplanted first, followed by the heart, which helps to lower rejection rates for patients with elevated antibody levels. This method is particularly beneficial for patients on mechanical assist devices, as it minimizes the risk of immune rejection by decreasing the levels of donor-specific alloantibodies.
Dates and Times
Start: 3/25/2026 12:00 PM
End: 3/25/2026 1:00 PM
Objectives
At the conclusion of this educational presentation, the participant will be able to
A. describe strategies for managing end stage heart failure patients with different levels of allosensitization
B. discuss the indications for heart after liver transplantation with or without domino (HALT+/-D)
C. explain the outcomes of patients who have undergone HALT+/-D
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.